Lisa Bodei News Today : Breaking News, Live Updates & Top Stories | Vimarsana

This year’s Mid-Winter Conference of the Society of Nuclear Medicine and Molecular Imaging (SNMMI) drew global experts exchanging the latest innovations in diagnostic and molecular imaging, cancer therapies, clinical trials and theranostics, as well as the potential role of artificial intelligence (AI) in nuclear medicine during the Feb. 1-3, 2024 meeting in Orlando, FL.

A simple blood draw can provide physicians with valuable information that can determine if peptide receptor radionuclide therapy (PRRT) is likely to be effective in a patient with neuroendocrine cancer.

/PRNewswire/ -- The Prostate Cancer Foundation (PCF) today announced four inaugural Class of 2022 TACTICAL (Therapy ACceleration To Intercept CAncer Lethality)...

Credit: Society of Nuclear Medicine and Molecular Imaging. Reston, Virginia--The Journal of Nuclear Medicine (JNM) has issued a special supplement commemorating six decades of leadership in the field of nuclear medicine, molecular imaging and therapy. The supplement features a collection of the most influential and frequently cited manuscripts in JNM's history, representing seminal discoveries and scientific contributions that shaped the future of medicine. Invited perspectives from world leaders in nuclear medicine, molecular imaging, and theranostics explain why each of these articles had ...